24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
IPO
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:02
Rafael’s Spyder enters Czech service as Prague considers more Israeli air defense systems
21:35
Netanyahu calls off Elon Musk meeting as U.S. trip is sharply shortened
20:19
Anthropic considers new model to counter OpenAI’s latest AI push
19:52
Google’s Gemini hacked real companies during a cyber test linked to Israeli startup Irregular
More stories
Buzz
Most popular
Daily
Weekly
1
Netanyahu calls off Elon Musk meeting as U.S. trip is sharply shortened
2
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
3
Serbia opens Israeli drone factory as defense ties with Elbit deepen
4
The man who helped build Palo Alto’s Cortex is leaving the company
5
What Nebius really bought when it bought Tavily
More news
IPO
20 stories about IPO
CEO of Israeli E-commerce Group Resigns after Failed Tel Aviv IPO Attempt
28.10.18
|
Adi Pick
Ilan Tzachi, CEO OF Zap Group, announced on Sunday his intention to resign, concluding his tenure in January 2019
Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO
28.10.18
|
Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO
21.10.18
|
Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million
18.10.18
|
Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
IT and Analytics Company Elastic Catapults on NYSE IPO
07.10.18
|
Meir Orbach
The Israel-linked company closed 94% up on its first trading day, after raising $252 million at above the original prospectus price
Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO
30.09.18
|
Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
Communication Equipment Firm ECI Confirms Plans for London IPO
20.09.18
|
Golan Hazani
ECI seeks to raise around $230 million in new and existing shares, according to the company’s registration documents
Israel to Privatize National Postal Company
06.08.18
|
Zvi Zerahia
On Sunday, a parliamentary committee approved a decision to sell 40% of the company to strategic investors and the public. 60% will remain state-owned
Medical Device Company Medigus Raises $10 Million in Public Offering
24.07.18
|
CTech
Medigus develops minimally invasive endosurgical tools and direct visualization technology
As Market Matures, Israeli Tech Exits Continue to Diminish, Report Says
11.07.18
|
Hagar Ravet
The downward trend in the number of exits in Israel since 2015 continues, with 58 deals recorded between January and June 2018, compared to 63 deals in the first half of 2017
Cybersecurity Company Safe-T Group Submits Preliminary Prospectus for Nasdaq IPO
08.07.18
|
Lilach Baumer
The company is currently listed on the Tel Aviv Stock Exchange and on the OTCQB venture market
Cybersecurity Company ThetaRay Raises $30 Million
03.07.18
|
Golan Hazani
Founded in 2013, ThetaRay uses machine learning algorithms to detect system behavior anomalies and threats such as ATM hacking, insurance fraud, and SWIFT-based attacks
CTech's Sunday Roundup of Israeli Tech News
01.07.18
|
CTech
The Israeli military has big plans for small drones. Volkswagen sees blockchain-enabled cars in Its future.
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Gives Nasdaq IPO Another Shot
21.05.18
|
Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
Cellular Services Company Celltick Plans Tel Aviv IPO to Finance Growth
07.05.18
|
Amir Rosenbaum
The company is looking to raise up to $15 million, listing 15% of its existing shares
Nasdaq-Listed Diabetes Monitoring Company Dario Considering Dual Tel Aviv Registration
03.05.18
|
Golan Hazani
Dario develops a device that enables users to test and track their blood-glucose levels in real time using their smartphones
Attempting to Delist, Cancer Treatment Company BioCanCell Issues New Shares
23.04.18
|
Dror Reich
The company diluted existing investors that opposed its plans to delist from the Tel Aviv Stock Exchange
Israeli Surveillance Company Verint Considers an IPO for its Security Intelligence Division
28.03.18
|
Golan Hazani
After a failed attempt to sell the division, Verint mulls an IPO of the sub-unit according to a market value of $800 million
CTech’s Sunday Roundup of Israeli Tech News
25.03.18
|
CTech
U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO
Previous Articles
More Articles